Biomarkers of Acute Lung Injury The Individualized Approach: for Phenotyping, Risk Stratification and Treatment Surveillance

Journal of Clinical Medicine
Daniel D MurrayJens Ulrik Jensen

Abstract

Do we need biomarkers of lung damage and infection: For what purpose and how should they be used properly? Biomarkers of lung damage can be used for diagnosis, risk stratification/prediction, treatment surveillance and adjustment of targeted therapy. Additionally, novel "omics" methods may offer a completely different and effective way of improving the understanding of pathogenesis of lung damage and a way to develop new candidate lung damage biomarkers. In the current review, we give an overview within the field of acute lung damage of (i) disease mechanism biomarkers, (ii) of "ready to use" evidence-based biomarker-guided lung infection management, (iii) of novel strategies of inflammatory phenotyping and how this can be used to tailor corticosteroid treatment, (iv) a future perspective of where "omics" technologies and mindsets may become increasingly important in developing new strategies for treatment and for understanding the development of acute lung damage.

References

May 14, 1992·The New England Journal of Medicine·W M Lee, R M Galbraith
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J G HaddadJ W Sanger
Sep 16, 2000·American Journal of Respiratory and Critical Care Medicine·H TakahashiS Abe
Oct 31, 2003·Thorax·M D EisnerUNKNOWN Acute Respiratory Distress Syndrome Network
Dec 19, 2003·The European Respiratory Journal·A BlombergA Bernard
Jan 24, 2004·The European Respiratory Journal·H SatoT W Evans
Feb 16, 2007·The European Respiratory Journal·R SivaI D Pavord
Aug 10, 2007·Nature Biotechnology·Susanna-Assunta SansoneOliver Fiehn
Aug 10, 2007·Nature Biotechnology·Chris F TaylorHenning Hermjakob
Aug 10, 2007·Nature Biotechnology·Sandra OrchardHenning Hermjakob
May 10, 2008·Nature Biotechnology·Dawn FieldAnil Wipat
Oct 15, 2008·Archives of Internal Medicine·Matthias BrielMirjam Christ-Crain
Sep 10, 2009·JAMA : the Journal of the American Medical Association·Philipp SchuetzUNKNOWN ProHOSP Study Group
Mar 27, 2012·American Journal of Respiratory and Critical Care Medicine·Mona BafadhelChristopher E Brightling
May 17, 2012·Microbial Informatics and Experimentation·Torsten ThomasFolker Meyer
Apr 15, 2014·American Journal of Physiology. Lung Cellular and Molecular Physiology·Angela J Rogers, Michael A Matthay
May 24, 2014·The Lancet. Respiratory Medicine·Carolyn S CalfeeUNKNOWN NHLBI ARDS Network
Oct 18, 2014·The European Respiratory Journal·Dave SinghUNKNOWN ECLIPSE investigators
Jan 16, 2015·Seminars in Thrombosis and Hemostasis·Maria E JohansenJens-Ulrik Jensen
May 2, 2015·American Journal of Respiratory and Critical Care Medicine·Matthieu JabaudonJean-Michel Constantin
Jun 25, 2015·Respiratory Care·Vivek N AmbadeDashrath R Basannar
Dec 8, 2015·American Journal of Respiratory and Critical Care Medicine·Signe Vedel-KroghBørge G Nordestgaard
Jan 16, 2016·Therapeutic Advances in Chronic Disease·Leena George, Christopher E Brightling
Jul 7, 2016·International Journal of Chronic Obstructive Pulmonary Disease·Caspar CortiJens-Ulrik Jensen
Oct 13, 2016·ERJ Open Research·Jantina C de GrootAnneke Ten Brinke
Oct 27, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Simone M C SpoorenbergUNKNOWN Ovidius Study Group
Jun 15, 2017·Respiratory Research·Rachel L ZemansRussell P Bowler
Jul 1, 2017·The Lancet. Respiratory Medicine·Nuala J Meyer, Carolyn S Calfee
Aug 5, 2017·Respiratory Research·Mengyuan KanBlanca E Himes
Sep 2, 2017·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Henning StenbergEllen Tufvesson
Sep 3, 2017·The Lancet. Respiratory Medicine·Brendon P SciclunaUNKNOWN MARS consortium
Dec 1, 2017·Current Opinion in Allergy and Clinical Immunology·Giorgio W CanonicaEnrico Heffler
Feb 10, 2018·American Journal of Respiratory and Critical Care Medicine·Christian BimeJoe G N Garcia

❮ Previous
Next ❯

Citations

Dec 11, 2019·Journal of Clinical Medicine·Gaetano Perchiazzi, Hermann Wrigge
Oct 2, 2021·Experimental and Therapeutic Medicine·Jie LiWeiqing Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
lavage

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Pulmonary Medicine
Kian F Chung
American Journal of Respiratory and Critical Care Medicine
Bruce C Trapnell
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology
Howard S Fox
© 2021 Meta ULC. All rights reserved